After price cap, local stent makers capture 60% of market
Price regulation has also allowed better margins to Indian companies even as locally made, lower-priced products gain in the market, helping local players increase revenues. The share of Indian companies in terms of value has increased from 30% in 2016-17 to over 55% in 2019-20.
NPPA defers decision on Meril’s stent pricing plea
Meril Life’s first locally made biodegradable cardiac scaffold, a naturally dissolving ste...
Patients' group opposes stent categorisation
In April 2015 and January 2018, expert committees examining the request for separate categories ...
Panel likely to study stent companies' demand on price cap
With the committee not finding any “therapeutic advantage” in these stents that favours price exemption, the issue is likely to be sent to an inter-ministerial group of experts.
Everstone picks up minority stake in stent company Translumina
Deal worth Rs 500 crore to help Indian stent maker acquire global assets, boost R&D efforts
Govt considering to let US companies make medical devices in India
India is mulling a proposal to ask American companies to produce medical devices locally.
Government to drop 500 existing health packages, include 250 new ones
The discontinued packages include renal angioplasty with single stent (medicated) and eversion of hydrocele sac — unilateral.
Hospitals still not displaying medical device prices, consumer groups say
As per survey, 50% of the respondents said that medical devices they came across, did not have MRPs.
NPPA approves hike in prices of coronary stents
As per the new prices notified by the National Pharmaceutical Pricing Authority (NPPA), a bare metal stent (BMS) would now cost Rs 8,261, while the drug eluting stent (DES) will cost Rs 30,080.
You can get health insurance despite lifestyle diseases but at higher premium
Despite paying higher premiums, you may have to pay from your pocket in the initial years in case of waiting periods.
Hopeful of settlement between India and US over GSP conflict: Advamed
In 2017 India was the biggest beneficiary of GSP with a subsidies worth $5.6 billion.
It’s official, Indian-made stents as good as the best
A study presented two months back had also concluded that another Indian stent, Supra Flex was as good as Xience.
Made in India coronary stents as good as foreign ones: Study
The study dispels the perception among many doctors and patients that stents made in India may not be as safe and efficacious as those manufactured in foreign countries.
Abbott India stops importing Xience Alpine stents
Abbott becomes the first company to officially stop imports of the drug-eluting cardiac stents on account of the price curbs.
Price control on stents to continue: Govt
Industry asked to be prepared to meet demand for medical devices, even as the Centre is laying grounds for the launch of its mega healthcare scheme.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service